Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume 153, Issue 3, Pages 486-497Publisher
WILEY
DOI: 10.1111/j.1365-2133.2005.06893.x
Keywords
biologics; efalizumab; etanercept; guideline; infliximab; psoriasis